Business Advisory Board
Harry Lander, PhD, MBA
Dr. Lander has over 20 years of professional scientific, business and financial management experience related to biomedical research. Dr. Lander has had extensive experience in establishing the Sidra Medical and Research Center in Qatar as well as the implementation of a $650MM research building at the Weill Cornell Medical College . He has extensive relationships with large and small biotechnology / pharmaceutical companies and entities that Brunei Cancer Center can leverage for economic and scientific growth. Dr. Lander is currently President of Regen BioPharma, Inc. a publicly traded biotechnology company. Formerly he has served as Research Chief / Administration for Sidra Medical and Research Center (Doha, Qatar) and Assistant Provost for Weill Cornell Medical College (Cornell University). He has extensive experience running complex organizations and establishing new ones.
John Peck, Jr.
John Peck Jr graduated from Northern Illinois University in 1966 with a BS in Business. He spent the next three years in the US Army as an ordinance officer stationed in Southeast Asia. Upon returning to the States in 1969 he worked for RCA and Intel while pursuing an MBA at Depaul University. In 1976 John joined Meridian Leasing as employee number 5. In 1994 John (now CEO) and a Partner purchased Meridian Leasing (now 150 strong) from ownership that was in a consolidation mode. John’s share was bought out in 1997 and he started investing in commercial real estate with an emphasis on the large Multifamily properties. Currently John is doing a little land development work and has found the “New Wave of the Future”in the Biotech Community. At present he is invested in 7 Biotech firms. John and his wife,Vera, have been married for over 45 years and have had two children.
Nimesh Goel, BSN
Nimesh Goel graduated with a BSN from West Coast University in California. He is a founder of multiple startups with the vision to achieve innovation in healthcare technology. He founded BrewMed, a company focused on developing medical devices for all professionals, with a keen focus on improving patient care. Nimesh is also a cofounder of Dyo Biotechnologies, a company focused on delivering end-to-end precision medicine solutions to organizations and institutions across the globe. His clinical experiences have enabled him to identify solutions to enhance patient care, he has filed several patents over the years for his inventions. His experience in managing the startups has included authoring various patent applications, secured funding from investors, leading the R&D for his devices, contracting manufacturing companies throughout Asia and integrating scalability solutions. In addition, he has managed logistics, trained and deployed a sales force, negotiated with various distribution channels, and managed company financials. His array of experience and visionary outlook has enabled him to identify and optimize new opportunities for continual business development.